FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
09/07/2026
Voltar para busca
Dado oficial do USPTO
CONCIZUTRACE
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
CONCIZUTRACE
ST13
US500000079387857Classe
1, 5, 10, 44
Pedido
79387857
Registro
8054628
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
31
Atualização mais recente
09/07/2026
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 10, 44
Data de depósito
22/06/2023
Data de registro
09/12/2025
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
09/12/2025
Última transação
09/07/2026
Escritório responsável
United States Patent and Trademark Office
Código da situação
700
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
99
Localização do titular
GB
Examinador
DONEGAN, DANIEL P
Localização atual
FILE REPOSITORY (FRANCONIA)
Titulares e representantes
Titulares
Randox Laboratories Limited
Representantes
Daniel D. Frohling LOEB & LOEB LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 10Classe 44
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicals for use in industryscience and photographyas well as in agriculturehorticulture and forestryexcept fungicidesherbicidesinsecticidesparasiticides; diagnostic preparations for scientific purposes; chemical reagentsother than for medical or veterinary purposes; enzymes and proteins for industrial use; diagnostic preparations for analysis of food products and water for scientific and research purposes; diagnostic testing materials in the nature diagnostic reagents for scientific use
Classe 5
Pharmaceuticalveterinary and sanitary preparations and substances for use in medical clinical analysis and testing in connection with diagnosing cardiovascular diseasescoronary heart diseasebrain diseasescancerdiabeteskidney diseasesrenal diseasesanemiadementianervous system dysfunctionsdiseases of the central nervous systemautoimmune diseasesallergyvascular diseasesinfertilitymenopauseearly or delayed pubertyreproductive or non-reproductive disordersgastrointestinal disordersdigestive diseases and conditionsmetabolic diseaseshypercalcemiathyroid diseasesbone disordersrespiratory diseasesinfectious diseasessexually transmitted diseasesurinary tract infectionstesting high or low levels of testosteronetesting for calcium absorptiontesting of blood levelsantimicrobial testingscreening for drug use blood sera and blood anti-serafor medical and veterinary use; diagnostic preparations and substances for medical and veterinary purposes; clinical diagnostic reagents for medical or veterinary use; clinical diagnostic reagents for medical and veterinary use in vitro and/or vivo use; diagnostic scanning agents for medical and veterinary use for in vivo use; diagnostic testing materials for medical use in the detection and monitoring of disease states in vitrochemical reagents for medical and veterinary use; clinical laboratory analytical instruments in the nature of clinical medical reagents; clinical medical reagents; reagents for use in diagnostic tests for medical and veterinary purposes; reagents for use with analyzers for medical and veterinary purposes; clinical medical diagnostic reagents; diagnostic scanning agentsfor medical purposes; diagnostic kits comprised of diagnostic test reagentsdiagnostic agentspreparations and substanceswash bufferassay buffermicrotiter plateacidification plateneutralization plate for use in medical clinical analysis and testing in connection with diagnosing cardiovascular diseasescoronary heart diseasebrain diseasescancerdiabeteskidney diseasesrenal diseasesanemiadementianervous system dysfunctionsdiseases of the central nervous systemautoimmune diseasesallergyvascular diseasesinfertilitymenopauseearly or delayed pubertyreproductive or non-reproductive disordersgastrointestinal disordersdigestive diseases and conditionsmetabolic diseaseshypercalcemiathyroid diseasesbone disordersrespiratory diseasesinfectious diseasessexually transmitted diseasesurinary tract infectionstesting high or low levels of testosteronetesting for calcium absorptiontesting of blood levelsantimicrobial testingscreening for drug use for medical purposes
Classe 10
Medical apparatus and instruments for medical usefor use in vitro diagnostic testing procedures to detect and diagnose drug residues used in immunoassay procedures and for use in measuring blood proteinsantibodiesenzymesimmunoglobulins and hormones; diagnostic apparatus and instruments for medical use use in vitro diagnostic testing procedures to detect and diagnose drug residues used in immunoassay procedures and for use in measuring blood proteinsantibodiesenzymesimmunoglobulinshormones and drugs; diagnostic imaging apparatus for medical use; clinical analyzers for use in measuring blood proteinsantibodiesenzymesimmunoglobulinshormones and drugs for medical and veterinary use; diagnostic testing apparatus and instruments for use in immunoassay proceduresfor use in the measurement of antibodiesimmunoglobulinshormones and drugs representing various drug classes; detectors and diagnostic testing apparatus and instruments for use in immunoassay procedures to detect and diagnose drug residues used in immunoassay procedures and for use in measuring blood proteinsantibodiesenzymesimmunoglobulinshormones and drugs; parts and fittings for all the aforesaid goodsx-ray diagnostic apparatusultrasound diagnostic apparatusprobes for use in in vitro diagnostic testing proceduresclinical chemistry analyzersblood testing apparatus; clinical laboratory analytical instruments in the nature x-ray diagnostic apparatusultrasound diagnostic apparatusprobes for use in in vitro diagnostic testing proceduresclinical chemistry analyzersblood testing apparatusdiagnostic saliva vialsall being clinical laboratory analytical instruments for medical or veterinary use
Classe 44
Medical services; hygienic and beauty care for human beings; consulting services relating to health care; health advice and information services; medical care services in the field of general healthimmunologynutritioncardiac diseasesmetabolismcancerdiabetesfertilitythyroid function; health clinic services; healthcare services; medical consultations and lifestyle consultationsprofessional consultations to individuals to assess their personal health and health wellbeing; medical health assessment services; health screening services in the field of general healthimmunologynutritioncardiac diseasesmetabolismcancerdiabetesfertilitythyroid function; diagnostic health screening services in the field of general healthimmunologynutritioncardiac diseasesmetabolismcancerdiabetesfertilitythyroid function; providing medical information to patients in the form of preparation of reports in the field of general healthimmunologynutritioncardiac diseasesmetabolismcancerdiabetesfertilitythyroid function relating to health care matters; professional consultancy relating to health; medical testing; testing and analysis in the nature of medical diagnostic services; nursing services; nursing care services; medical health and fitness assessment servicesfor medical purposes; medical advisory and consultancy services relating to immunology; advisory and consultancy services relating to nutrition; cholesterol testing; genetic testing for medical purposes; hearing tests; services for the testing of bloodfor medical purposes; services for the medical testing of blood sera; services for the medical testing of urine; services for medical testing of bone functions; services for medical testing of major body organs; services for the medical testing of fertility hormone levels; health screening in the field of health care for pregnant women; pregnancy testing services; prenatal medical care services; postnatal care services in the nature of deficiency diagnostics and personalized health plans; services for the medical testing of diabetes; services for the medical testing of thyroid function; services for medical testing of blood iron levels; medical assistance; medical clinics; informationconsultancy and advice relating to any of the aforesaid services
Publicações
Histórico de despachos e eventos da marca no USPTO.
31 publicações encontradas
FICS
FINAL DISPOSITION NOTICE SENT TO IB
20/06/2026
FIMP
FINAL DISPOSITION PROCESSED
20/06/2026
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
09/03/2026
NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
09/12/2025
R.PR
REGISTERED-PRINCIPAL REGISTER
09/12/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
21/10/2025
PUBO
PUBLISHED FOR OPPOSITION
21/10/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
15/10/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
19/09/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
24/07/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
24/07/2025
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
24/07/2025
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
11/07/2025
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
24/06/2025
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
24/06/2025
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
27/01/2025
GNFR
FINAL REFUSAL E-MAILED
27/01/2025
CNFR
FINAL REFUSAL WRITTEN
27/01/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
27/09/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
27/09/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
27/09/2024
RFNT
REFUSAL PROCESSED BY IB
24/04/2024
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
29/03/2024
RFRR
REFUSAL PROCESSED BY MPU
29/03/2024
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
12/03/2024
CNRT
NON-FINAL ACTION WRITTEN
11/03/2024
DOCK
ASSIGNED TO EXAMINER
11/03/2024
MAFR
APPLICATION FILING RECEIPT MAILED
30/01/2024
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
26/01/2024
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
25/01/2024
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace CONCIZUTRACE ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.